Cancer drug expenditure in British Columbia and Saskatchewan: a trend analysis.

ABSTRACT:

Background

Expenditure on systemic therapy for cancer has been increasing quickly owing to population growth, increased use, both in the number of users and in prescription volume, and rising drug prices. Our objective was to describe trends in expenditure in British Columbia and Saskatchewan's cancer care systems and to elucidate these drivers of growth.

Methods

In this trend analysis, we obtained pharmacy dispensing records from the BC Cancer and Saskatchewan Cancer Agency pharmacies for all anticancer therapies dispensed in 2006-2013. We calculated total annual expenditure directly from the data and conducted a trend analysis of crude and standardized annual expenditure using generalized linear models. We estimated trends in the following components of total expenditure:

SUBMITTER: Pataky R 

PROVIDER: S-EPMC6182106 | biostudies-literature | 2018 Jul-Sep

REPOSITORIES: biostudies-literature